148 related articles for article (PubMed ID: 14969668)
1. Three-year efficacy and acceptability of the GyneFix 200 intrauterine system.
Cao X; Zhang W; Zhao X; Lin N; Wang L; Li C; Song L; Zhang W; Zhang Z; Wildemeersch D
Contraception; 2004 Mar; 69(3):207-11. PubMed ID: 14969668
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of a mini version of the frameless GyneFix intrauterine system (IUS) with effective copper surface area of 200 mm2. dirk.wildemeersch@contrel.be.
Wildemeersch D; Cao X; Zhang W; Zhao X; Lin N; Wang L; Li C; Song L; Zhang W; Zhang Z; Delbarge W
Contraception; 2002 Oct; 66(4):237-41. PubMed ID: 12413618
[TBL] [Abstract][Full Text] [Related]
3. The Femilis LNG-IUS: contraceptive performance-an interim analysis.
Wildemeersch D; Janssens D; Andrade A
Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):103-10. PubMed ID: 19340705
[TBL] [Abstract][Full Text] [Related]
4. Ease of insertion, contraceptive efficacy and safety of new T-shaped levonorgestrel-releasing intrauterine systems.
Wildemeersch D; Janssens D; Vrijens M; Weyers S
Contraception; 2005 Jun; 71(6):465-9. PubMed ID: 15914138
[TBL] [Abstract][Full Text] [Related]
5. Return to fertility in nulliparous and parous women after removal of the GyneFix intrauterine contraceptive system.
Delbarge W; Bátár I; Bafort M; Bonnivert J; Colmant C; Dhont M; Fonzé V; Gevers R; Janssens D; Lavalley P; Salmin E; Degueldre M; Vrijens M; Van Kets H; Wildemeersch D
Eur J Contracept Reprod Health Care; 2002 Mar; 7(1):24-30. PubMed ID: 12041861
[TBL] [Abstract][Full Text] [Related]
6. Assessment of menstrual blood loss in Brazilian users of the frameless copper-releasing IUD with copper surface area of 330 mm2 and the frameless levonorgestrel-releasing intrauterine system.
Andrade AT; Souza JP; Andrade GN; Rowe PJ; Wildemeersch D
Contraception; 2004 Aug; 70(2):173-7. PubMed ID: 15288225
[TBL] [Abstract][Full Text] [Related]
7. [Randomized comparative study of GyneFix IN and TCu 380A intrauterine devices].
Wu S; Hu J; Wu M
Zhonghua Fu Chan Ke Za Zhi; 1998 Jun; 33(6):345-8. PubMed ID: 10806672
[TBL] [Abstract][Full Text] [Related]
8. Use of frameless intrauterine devices and systems in young nulliparous and adolescent women: results of a multicenter study.
Wildemeersch D; Jandi S; Pett A; Nolte K; Hasskamp T; Vrijens M
Int J Womens Health; 2014; 6():727-34. PubMed ID: 25125987
[TBL] [Abstract][Full Text] [Related]
9. Assessment of menstrual blood loss in Belgian users of the frameless copper-releasing IUD with copper surface area of 200 mm2 and users of a copper-levonorgestrel-releasing intrauterine system.
Wildemeersch D; Rowe PJ
Contraception; 2004 Aug; 70(2):169-72. PubMed ID: 15288224
[TBL] [Abstract][Full Text] [Related]
10. [Intrauterine copper contraceptive implants].
Van Kets H; Thiery M; Wildemeersch D; Delbarge W; Vrijens M; Van der Pas H; Depypere H; Parewijck W; Temmerman M; Van Trappen Y; Van den Ostende G
Contracept Fertil Sex; 1996 Dec; 24(12):908-11. PubMed ID: 9026279
[TBL] [Abstract][Full Text] [Related]
11. New frameless and framed intrauterine devices and systems - an overview.
Wildemeersch D
Contraception; 2007 Jun; 75(6 Suppl):S82-92. PubMed ID: 17531623
[TBL] [Abstract][Full Text] [Related]
12. Performance of the frameless GyneFix and the TCu380A IUDs in a 3-year multicenter, randomized, comparative trial in parous women.
Wu S; Hu J; Wildemeersch D
Contraception; 2000 Feb; 61(2):91-8. PubMed ID: 10802273
[TBL] [Abstract][Full Text] [Related]
13. Randomized comparative trial in parous women of the frameless GyneFix and the TCu380A intrauterine devices: long-term experience in a Chinese family planning clinic.
Cao X; Zhang W; Gao G; Van Kets H; Wildemeersch D
Eur J Contracept Reprod Health Care; 2000 Jun; 5(2):135-40. PubMed ID: 10943576
[TBL] [Abstract][Full Text] [Related]
14. The Nova-T 200 intrauterine contraceptive device: a 12 year study.
Baeyertz JD; Hartfield VJ
N Z Med J; 1997 May; 110(1043):169-71. PubMed ID: 9196502
[TBL] [Abstract][Full Text] [Related]
15. The frameless copper IUD (GyneFix) and the TCu380A IUD: results of an 8-year multicenter randomized comparative trial.
Meirik O; Rowe PJ; Peregoudov A; Piaggio G; Petzold M;
Contraception; 2009 Aug; 80(2):133-41. PubMed ID: 19631788
[TBL] [Abstract][Full Text] [Related]
16. The reliability of the anchoring concept for suspension of bioactive substances in the human uterus evaluated by measuring the removal force: results after long-term use.
Batár I; Wildemeersch D
Contraception; 2004 Jun; 69(6):501-3. PubMed ID: 15157797
[TBL] [Abstract][Full Text] [Related]
17. Intrauterine devices: an effective alternative to oral hormonal contraception.
Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
[TBL] [Abstract][Full Text] [Related]
18. GyneFix: a UK experience.
Geyoushi BE; Randall S; Stones RW
Eur J Contracept Reprod Health Care; 2002 Mar; 7(1):7-14. PubMed ID: 12041865
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness, safety, and acceptability of postplacental insertion of GyneFix postpartum intrauterine device among women undergoing cesarean section: A multicenter prospective cohort study in China.
Che Y; Hou GF; Zhang HP; Yang H; Lin SJ; Gan T; Yang WH; Shi CH; Ren WJ; Xu YQ; Yin BM; Chen TT; Gan YJ; Zhang Y; Zhang Y; Cheng LN
Contraception; 2023 Jun; 122():109999. PubMed ID: 36849032
[TBL] [Abstract][Full Text] [Related]
20. The force required to remove the frameless 0-suture IUD anchoring system: comparison between pre- and postmenopausal women.
Wildemeersch D
Contraception; 2004 Jun; 69(6):513-5. PubMed ID: 15157799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
